Immutep Ltd. Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Dec 23, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
IMMUTEP files routine 6-K, no major news.
AI Summary
Immutep Ltd. filed a Form 6-K on December 23, 2025, reporting its status as a foreign private issuer. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and has its principal executive offices in Sydney. This filing does not appear to contain specific financial updates or material events beyond its routine reporting requirements.
Why It Matters
This filing confirms Immutep's ongoing compliance with SEC reporting obligations as a foreign private issuer, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing that does not appear to contain new material information or significant financial changes.
Key Players & Entities
- IMMUTEP Ltd (company) — Filer of the report
- Prima BioMed Ltd (company) — Former name of the registrant
- 001-35428 (dollar_amount) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer publishes or is required to publish in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on December 23, 2025.
What is the SEC file number for Immutep Ltd?
The SEC file number for Immutep Ltd is 001-35428.
Has Immutep Ltd. changed its name previously?
Yes, Immutep Ltd. was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
Where are Immutep Ltd.'s principal executive offices located?
Immutep Ltd.'s principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Filing Stats: 264 words · 1 min read · ~1 pages · Grade level 17.4 · Accepted 2025-12-22 20:11:51
Filing Documents
- d93446d6k.htm (6-K) — 10KB
- d93446dex991.htm (EX-99.1) — 16KB
- g93446g1222222808082.jpg (GRAPHIC) — 5KB
- g93446g1222222808249.jpg (GRAPHIC) — 1KB
- 0001193125-25-329186.txt ( ) — 36KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 22, 2025 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer